[HTML][HTML] A Dual Pharmacological Strategy against COVID-19: The Therapeutic Potential of Metformin and Atorvastatin
LA De Jesús-González, RM Del Ángel… - Microorganisms, 2024 - mdpi.com
Metformin (MET) and atorvastatin (ATO) are promising treatments for COVID-19. This review
explores the potential of MET and ATO, commonly prescribed for diabetes and dyslipidemia …
explores the potential of MET and ATO, commonly prescribed for diabetes and dyslipidemia …
[HTML][HTML] A Dual Pharmacological Strategy against COVID-19: The Therapeutic Potential of Metformin and Atorvastatin
LA De Jesús-González, RM del Ángel… - …, 2024 - ncbi.nlm.nih.gov
Metformin (MET) and atorvastatin (ATO) are promising treatments for COVID-19. This review
explores the potential of MET and ATO, commonly prescribed for diabetes and dyslipidemia …
explores the potential of MET and ATO, commonly prescribed for diabetes and dyslipidemia …
A Dual Pharmacological Strategy against COVID-19: The Therapeutic Potential of Metformin and Atorvastatin
D Jesús-González, R del Ángel… - …, 2024 - europepmc.org
Metformin (MET) and atorvastatin (ATO) are promising treatments for COVID-19. This review
explores the potential of MET and ATO, commonly prescribed for diabetes and dyslipidemia …
explores the potential of MET and ATO, commonly prescribed for diabetes and dyslipidemia …
[PDF][PDF] A Dual Pharmacological Strategy against COVID-19: The Therapeutic Potential of Metformin and Atorvastatin
LA De Jesús-González, RM del Ángel… - infection, 2024 - researchgate.net
Metformin (MET) and atorvastatin (ATO) are promising treatments for COVID-19. This review
explores the potential of MET and ATO, commonly prescribed for diabetes and dyslipidemia …
explores the potential of MET and ATO, commonly prescribed for diabetes and dyslipidemia …
A Dual Pharmacological Strategy against COVID-19: The Therapeutic Potential of Metformin and Atorvastatin
LA De Jesús-González, RM Del Ángel… - …, 2024 - pubmed.ncbi.nlm.nih.gov
Metformin (MET) and atorvastatin (ATO) are promising treatments for COVID-19. This review
explores the potential of MET and ATO, commonly prescribed for diabetes and dyslipidemia …
explores the potential of MET and ATO, commonly prescribed for diabetes and dyslipidemia …
A Dual Pharmacological Strategy against COVID-19: The Therapeutic Potential of Metformin and Atorvastatin.
DJG LA, RM Del Ángel, SN Palacios-Rápalo… - …, 2024 - europepmc.org
Metformin (MET) and atorvastatin (ATO) are promising treatments for COVID-19. This review
explores the potential of MET and ATO, commonly prescribed for diabetes and dyslipidemia …
explores the potential of MET and ATO, commonly prescribed for diabetes and dyslipidemia …